Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR

Journal of Neuroscience Methods

Volumn 77, Issue 1, 1997, Pages 83-92

  Johnston, Nancy L ^a   Cerevnak, Juraj ^b   Shore, Andrew D ^c   Fuller Torrey, E ^b   Yolken, Robert H ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Glyceraldehyde phosphate dehydrogenase; PH; Postmortem human brain; Psychiatric disorders; RNA; RT PCR

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE;

ARTICLE; BRAIN LEVEL; CADAVER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENTAL DISEASE; MULTIVARIATE ANALYSIS; PH; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

AUTOPSY; DEMOGRAPHY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; HYDROGEN-ION CONCENTRATION; MULTIVARIATE ANALYSIS; OCCIPITAL LOBE; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0030668729     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(97)00115-5     Document Type: Article

References (23)

1. Barton AJL, Pearson RCA, Najilerahim A, Harrison PJ Pre- and postmortem influences on brain mRNA. J Neurochem. 61:1993;1-11.
2. Bernstein P, Peltz SW, Ross J The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol Cell Biol. 9:1989;659-670.
3. Bowen DM, Smith CB, White P, Davidson AN Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain. 99:1976;459-496.
4. Butterworth J, Yates CM, Simpson J Phosphate activated glutaminase in relation to Huntington's disease and agonal state. J Neurochem. 41:1983;440-447.
5. Butterworth J Changes in nine enzyme markers for neurons, glia and endothelial cells in agonal state and Huntington's disease caudate nucleus. J Neurochem. 47:1986;583-587.
6. Czudek C, Reynolds GP 3H-nipecotic acid binding to g-aminobutyric acid uptake sites in post-mortem human brain. J Neurochem. 55:1990;165-168.
7. Dodd PR, Hambley JW, Cowburn RF, Hardy JA A comparison of methodologies for the study of functional transmitter neurochemistry in human brain. J Neurochem. 50:1988;1333-1345.
8. Hardy JA, Wester P, Winblad B, Gezelius C, Bring G, Eriksson A The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J Neural Transm. 61:1985;253-264.
9. Harrison PJ, Procter AW, Barton AJL, Lowe SL, Najlerahim A, Bertolucci PHF, Bowen DM, Pearson RCA Terminal coma affects messenger RNA detection in post mortem human temporal cortex. Mol Brain Res. 9:1991;161-164.
10. Harrison PJ, Heath PR, Eastwood SL, Burnet PWJ, McDonald B, Pearson RCA The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vunerability and comparison with their encoded proteins. Neurosci Lett. 200:1995;151-154.
11. Johnson SA, Morgan DG, Finch CE Extensive postmortem stability of RNA from rat and human brain. J Neurosci Res. 16:1986;267-280.
12. Kingsbury AE, Foster OJF, Nisbet AP, Cairns N, Bray L, Eve DJ, Lees AJ, Marsden CD Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Mol Brain Res. 28:1995;311-318.
13. Leonard S, Logel J, Luthman D, Casanova M, Kirch D, Freedman R Biological stability of mRNA isolated from human postmortem brain collections. Biol Psych. 33:1993;456-466.
14. Morrison MR, Pardue S, Maschoff K, Griffin WST, White III CL, Gilbert J, Roses A Brain messenger RNA levels and ribonuclease activity in Alzheimer's disease. Biochem Soc Trans. 15:1987;133-134.
15. Octave J-N, de Sauvage F, Macq A-F, Maloteaux JM Cloning of the cDNA from normal brain and brain of patients with Alzheimer's disease in the expression vector lambda gt11. Prog Neuro-Psychopharmacol Biol Psychiatry. 12:1988;813-820.
16. Perrett CW, Marchbanks RM, Whatley SA Characterisation of messenger RNA extracted post-mortem from the brains of schizophrenic, depressed and control subjects. J Neurol Neurosurg Psychiatry. 51:1988;325-331.
17. Perry EK, Perry RH, Tomlinson BE The influence of agonal states on some neurochemical activities of postmortem human brain tissue. Neurosci Lett. 29:1981;303-307.
18. Pindyck RS, Rubinfeld DL, Econometric Models and Economic Forecasts. 2nd ed. New York: McGraw-Hill, 1981:630.
19. Ragsdale DS, Miledi R Expressional potency of mRNAs encoding receptors and voltage-activated channels in the postmortem rat brain. Proc Natl Acad Sci USA. 88:1991;1854-1858.
20. Spokes EGS An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human postmortem brain tissue. Brain. 102:1979;333-346.
21. Taylor GR, Carter GI, Crow TJ, Johnson JA, Fairbairn AF, Perry EK, Perry RH Recovery and measurement of RNA in Alzheimer's disease by molecular hybridization. J Neurol Neurosurg Psychiatry. 50:1986;336.
22. Whatley SA, Curti D, Marchbanks RM Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem Res. 21:1996;995-1004.
23. Yates CM, Butterworth J, Tennant MC, Gordon A Enzyme activites in relation to pH and lactate in postmortem brain in Alzheimer's-type and other dementias. J Neurochem. 55:1990;1624-1630.